Răzvan Popescu

3.8k total citations
63 papers, 1.7k citations indexed

About

Răzvan Popescu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Information Systems. According to data from OpenAlex, Răzvan Popescu has authored 63 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 15 papers in Information Systems. Recurrent topics in Răzvan Popescu's work include Service-Oriented Architecture and Web Services (15 papers), Business Process Modeling and Analysis (11 papers) and Gastric Cancer Management and Outcomes (9 papers). Răzvan Popescu is often cited by papers focused on Service-Oriented Architecture and Web Services (15 papers), Business Process Modeling and Analysis (11 papers) and Gastric Cancer Management and Outcomes (9 papers). Răzvan Popescu collaborates with scholars based in Switzerland, Italy and United Kingdom. Răzvan Popescu's co-authors include David Cunningham, Paul J. Ross, A. Norman, Biren Parikh, Antonio Brogi, A. Z. S. Rohatiner, E.M. Bessell, Peter Johnson, James M. Foran and Michele Ghielmini and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Răzvan Popescu

60 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Răzvan Popescu Switzerland	17	927	510	394	273	252	63	1.7k
Timothy N. Showalter United States	31	707 0.8×	129 0.3×	1.6k 4.2×	264 1.0×	664 2.6×	215	3.5k
Frank Griesinger Germany	35	1.7k 1.8×	773 1.5×	1.7k 4.4×	948 3.5×	112 0.4×	275	5.1k
Tarec Christoffer El‐Galaly Denmark	25	675 0.7×	1.3k 2.5×	358 0.9×	314 1.2×	89 0.4×	160	2.0k
Erqi L. Pollom United States	27	924 1.0×	141 0.3×	1.0k 2.6×	407 1.5×	612 2.4×	195	2.8k
Philippe Coucke Switzerland	24	855 0.9×	168 0.3×	774 2.0×	54 0.2×	781 3.1×	140	2.4k
Raymond E. Lenhard United States	17	394 0.4×	349 0.7×	146 0.4×	173 0.6×	90 0.4×	49	998
Chirag Shah United States	34	1.6k 1.7×	979 1.9×	727 1.8×	38 0.1×	1.2k 4.7×	240	4.0k
J. L. Haybittle United Kingdom	30	1.5k 1.6×	839 1.6×	508 1.3×	102 0.4×	275 1.1×	91	3.3k
Chris Twelves United Kingdom	20	1.3k 1.4×	57 0.1×	507 1.3×	196 0.7×	88 0.3×	44	1.8k
A. Jo Chien United States	23	1.1k 1.2×	97 0.2×	288 0.7×	68 0.2×	82 0.3×	94	2.1k

Countries citing papers authored by Răzvan Popescu

Since Specialization

Citations

This map shows the geographic impact of Răzvan Popescu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Răzvan Popescu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Răzvan Popescu more than expected).

Fields of papers citing papers by Răzvan Popescu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Răzvan Popescu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Răzvan Popescu. The network helps show where Răzvan Popescu may publish in the future.

Co-authorship network of co-authors of Răzvan Popescu

This figure shows the co-authorship network connecting the top 25 collaborators of Răzvan Popescu. A scholar is included among the top collaborators of Răzvan Popescu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Răzvan Popescu. Răzvan Popescu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Templeton, Arnoud J., Stefanie Hayoz, Richard Cathomas, et al.. (2025). Osteonecrosis of the jaw (ONJ) in patients with metastatic castration resistant prostate cancer (mCRPC) treated with denosumab in a randomized phase III trial comparing 4 vs. 12 weekly administration (REDUSE, SAKK 96/12).. Journal of Clinical Oncology. 43(5_suppl). 163–163.

Rapoport, Bernardo L., Carme Font, Adnan Abdul Jabbar, et al.. (2023). A prospective, real-world, multinational study of febrile neutropenia (FN) occurrence in oncology patients receiving chemotherapy with intermediate risk of FN: a MASCC Neutropenia, Infection, and Myelosuppression Study Group initiative. Supportive Care in Cancer. 31(11). 628–628. 3 indexed citations

Georgescu, D., et al.. (2023). Double-J stent versus percutaneous nephrostomy for emergency upper urinary tract decompression. Journal of Medicine and Life. 16(5). 663–667. 1 indexed citations

Schmalz, Oliver, Christine Jacob, Blasius Liss, et al.. (2020). Digital Monitoring and Management of Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Treated With Cancer Immunotherapy and Its Impact on Quality of Clinical Care: Interview and Survey Study Among Health Care Professionals and Patients. Journal of Medical Internet Research. 22(12). e18655–e18655. 28 indexed citations

Petca, Răzvan, Răzvan Popescu, Claudia Mehedințu, et al.. (2019). Xanthogranulomatous pyelonephritis: presentation and management. SHILAP Revista de lepidopterología. 169–175. 6 indexed citations

Rothschild, Sacha I., Daniel Betticher, Sandro Anchisi, et al.. (2019). Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN study. Cancer Chemotherapy and Pharmacology. 84(4). 881–889. 6 indexed citations

Ades, Felipe, et al.. (2017). Are life-saving anticancer drugs reaching all patients? Patterns and discrepancies of trastuzumab use in the European Union and the USA. PLoS ONE. 12(3). e0172351–e0172351. 12 indexed citations

Koeberle, Dieter, Daniel Betticher, Roger von Moos, et al.. (2015). Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06). Annals of Oncology. 26(4). 709–714. 92 indexed citations

Ades, Felipe, Dimitrios Zardavas, Evandro de Azambuja, et al.. (2014). An exploratory analysis of the factors leading to delays in cancer drug reimbursement in the European Union: The trastuzumab case. European Journal of Cancer. 50(18). 3089–3097. 13 indexed citations

10.

Moos, Roger von, Arnaud Roth, Thomas Ruhstaller, et al.. (2010). Oxaliplatin, Irinotecan and Capecitabine (OCX) for First-Line Treatment of Advanced/Metastatic Colorectal Cancer: A Phase I Trial (SAKK 41/03). Onkologie. 33(6). 295–299. 3 indexed citations

11.

Brogi, Antonio & Răzvan Popescu. (2007). Automated Generation of BPEL Adapters.. CINECA IRIS Institutial research information system (University of Pisa). 387–400. 2 indexed citations

12.

Brogi, Antonio & Răzvan Popescu. (2006). Contract-based Service Aggregation. UnipiEprints Open Archive (Università di Pisa). 2 indexed citations

13.

Brogi, Antonio & Răzvan Popescu. (2006). BPEL2YAWL: Transalating BPEL processes into YAWL workflows. UnipiEprints Open Archive (Università di Pisa). 2 indexed citations

14.

Brogi, Antonio & Răzvan Popescu. (2006). Towards Semi-automated Workflow-based Aggregation of Web Services.. Conferencia Iberoamericana de Software Engineering. 9–22. 1 indexed citations

15.

Peters, Solange, Verena Voelter, Léonidas Zografos, et al.. (2006). Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patients. Annals of Oncology. 17(4). 578–583. 83 indexed citations

16.

Craven, Rachel A., Anthea J. Stanley, Sarah Hanrahan, et al.. (2004). Identification of proteins regulated by interferon‐α in resistant and sensitive malignant melanoma cell lines. PROTEOMICS. 4(12). 3998–4009. 12 indexed citations

17.

Foran, James M., Rajnish K. Gupta, David Cunningham, et al.. (2000). A UK multicentre phase II study of rituximab (chimaeric anti‐CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response. British Journal of Haematology. 109(1). 81–88. 93 indexed citations

18.

Popescu, Răzvan, Andrew Wotherspoon, David Cunningham, et al.. (1999). Surgery plus chemotherapy or chemotherapy alone for primary intermediate- and high-grade gastric non-Hodgkin's lymphoma: The Royal Marsden Hospital experience. European Journal of Cancer. 35(6). 928–934. 23 indexed citations

19.

Cunningham, David, Răzvan Popescu, F. Cavalli, et al.. (1998). Immunotherapy of mantle cell lymphoma (MCL), lymphoplasmacytoid lymphoma (LPC) and Waldenstrom's macroglobulinemia (WM), and small lymphocytic lymphoma (SLL) with rituximab (IDEC-C288): Preliminary results of an ongoing international multicentre trial. British Journal of Haematology. 102. 149–149. 3 indexed citations

20.

Waters, Justin S., Paul J. Ross, Răzvan Popescu, & David Cunningham. (1997). New Approaches to the Treatment of Gastro-lntestinal Cancer. Digestion. 58(6). 508–519. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact